Advertisement

Intensive Care Medicine

, Volume 41, Issue 12, pp 2130–2137 | Cite as

Benzodiazepine-associated delirium in critically ill adults

  • Irene J. Zaal
  • John W. Devlin
  • Marijn Hazelbag
  • Peter M. C. Klein Klouwenberg
  • Arendina W. van der Kooi
  • David S. Y. Ong
  • Olaf L. Cremer
  • Rolf H. Groenwold
  • Arjen J. C. Slooter
Original

Abstract

Purpose

The association between benzodiazepine use and delirium risk in the ICU remains unclear. Prior investigations have failed to account for disease severity prior to delirium onset, competing events that may preclude delirium detection, other important delirium risk factors, and an adequate number of patients receiving continuous midazolam. The aim of this study was to address these limitations and evaluate the association between benzodiazepine exposure and ICU delirium occurrence.

Methods

In a cohort of consecutive critically ill adults, daily mental status was classified as either awake without delirium, delirium, or coma. In a first-order Markov model, multinomial logistic regression analysis was used, which considered five possible outcomes the next day (i.e., awake without delirium, delirium, coma, ICU discharge, and death) and 16 delirium-related covariables, to quantify the association between benzodiazepine use and delirium occurrence the following day.

Results

Among 1112 patients, 9867 daily transitions occurred. Benzodiazepine administration in an awake patient without delirium was associated with increased risk of delirium the next day [OR 1.04 (per 5 mg of midazolam equivalent administered) 95 % CI 1.02–1.05). When the method of benzodiazepine administration was incorporated in the model, the odds of transitioning to delirium was higher with benzodiazepines given continuously (OR 1.04, 95 % CI 1.03–1.06) compared to benzodiazepines given intermittently (OR 0.97, 95 % CI 0.88–1.05).

Conclusions

After addressing potential methodological limitations of prior studies, we confirm that benzodiazepine administration increases the risk for delirium in critically ill adults but this association seems to be limited to continuous infusion use only.

Keywords

Delirium Benzodiazepine Midazolam Risk Intensive care 

Notes

Acknowledgments

John W. Devlin’s efforts towards this project were supported, in part, by a Visitor’s Grant from the Netherlands Organization for Scientific Research (NWO 040.11.372).

Compliance with ethical standards

Conflicts of interest

None of the authors have potential conflicts of interest regarding this manuscript.

Supplementary material

134_2015_4063_MOESM1_ESM.docx (211 kb)
Supplementary material 1 (DOCX 210 kb)

References

  1. 1.
    Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH (2009) Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 180:1092–1097PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Zaal IJ, Slooter AJ (2012) Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management. Drugs 72:1457–1471CrossRefPubMedGoogle Scholar
  3. 3.
    Pandharipande PP, Girard TD, Jackson JC et al (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369:1306–1316PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306CrossRefPubMedGoogle Scholar
  5. 5.
    Devlin JW, Fraser GL, Riker RR (2011) Drug-induced coma and delirium. In: Papadopoulos B, Cooper S, Kane-Gill SL, Mallow-Corbet JB (eds) Drug-induced complications in the critically ill patient: a guide for recognition and treatment, 1st edn. Society of Critical Care Medicine, ChicagoGoogle Scholar
  6. 6.
    Young J, Murthy L, Westby M, Akunne A, O’Mahony R (2010) Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ 341:c3704CrossRefPubMedGoogle Scholar
  7. 7.
    Morandi A, Brummel NE, Ely EW (2011) Sedation, delirium and mechanical ventilation: the ‘ABCDE’ approach. Curr Opin Crit Care 17:43–49CrossRefPubMedGoogle Scholar
  8. 8.
    Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD (2009) Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 37:3031–3039CrossRefPubMedGoogle Scholar
  9. 9.
    Pandharipande P, Shintani A, Peterson J et al (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104:21–26CrossRefPubMedGoogle Scholar
  10. 10.
    Kamdar BB, Niessen T, Colantuoni E et al (2015) Delirium transitions in the medical ICU: exploring the role of sleep quality and other factors. Crit Care Med 43:135–141CrossRefPubMedGoogle Scholar
  11. 11.
    Pandharipande P, Cotton BA, Shintani A et al (2008) Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 65:34–41PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Agarwal V, O’Neill PJ, Cotton BA et al (2010) Prevalence and risk factors for development of delirium in burn intensive care unit patients. J Burn Care Res 31:706–715PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Seymour CW, Pandharipande PP, Koestner T et al (2012) Diurnal sedative changes during intensive care: impact on liberation from mechanical ventilation and delirium. Crit Care Med 40:2788–2796PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Serafim RB, Dutra MF, Saddy F et al (2012) Delirium in postoperative nonventilated intensive care patients: risk factors and outcomes. Ann Intensive Care 2:51PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    van den Boogaard M, Pickkers P, Slooter AJ et al (2012) Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 344:e420PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Pandharipande PP, Morandi A, Adams JR et al (2009) Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med 35:1886–1892PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Schreiber MP, Colantuoni E, Bienvenu OJ et al (2014) Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med 42:1480–1486PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Svenningsen H, Egerod I, Videbech P, Christensen D, Frydenberg M, Tonnesen EK (2013) Fluctuations in sedation levels may contribute to delirium in ICU patients. Acta Anaesthesiol Scand 57:288–293CrossRefPubMedGoogle Scholar
  19. 19.
    Colombo R, Corona A, Praga F et al (2012) A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study. Minerva Anestesiol 78:1026–1033PubMedGoogle Scholar
  20. 20.
    Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y (2001) Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 27:1297–1304CrossRefPubMedGoogle Scholar
  21. 21.
    Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y (2007) Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 33:66–73CrossRefPubMedGoogle Scholar
  22. 22.
    Shi CM, Wang DX, Chen KS, Gu XE (2010) Incidence and risk factors of delirium in critically ill patients after non-cardiac surgery. Chin Med J (Engl) 123:993–999Google Scholar
  23. 23.
    Lin SM, Huang CD, Liu CY et al (2008) Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care 23:372–379CrossRefPubMedGoogle Scholar
  24. 24.
    Devlin JW, Zaal IJ, Slooter AJ (2014) Clarifying the confusion surrounding drug-associated delirium in the ICU. Crit Care Med 42:1565–1566CrossRefPubMedGoogle Scholar
  25. 25.
    Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP (2010) Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 111:451–463CrossRefPubMedGoogle Scholar
  26. 26.
    Hager DN, Dinglas VD, Subhas S et al (2013) Reducing deep sedation and delirium in acute lung injury patients: a quality improvement project. Crit Care Med 41:1435–1442CrossRefPubMedGoogle Scholar
  27. 27.
    Ely EW, Inouye SK, Bernard GR et al (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286:2703–2710CrossRefPubMedGoogle Scholar
  28. 28.
    Zaal IJ, Tekatli H, van der Kooi AW et al (2015) Classification of daily mental status in critically ill patients for research purposes. J Critical Care 30:375–380CrossRefGoogle Scholar
  29. 29.
    Sessler CN, Gosnell MS, Grap MJ et al (2002) The Richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338–1344CrossRefPubMedGoogle Scholar
  30. 30.
    van Eijk MM, van den Boogaard M, van Marum RJ et al (2011) Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med 184(3):340–344CrossRefPubMedGoogle Scholar
  31. 31.
    Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J (2012) Introduction to drug pharmacokinetics in the critically ill patient. Chest 141:1327–1336CrossRefPubMedGoogle Scholar
  32. 32.
    Vincent JL, de Mendonça A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:1793–1800CrossRefPubMedGoogle Scholar
  33. 33.
    Engels JM, Diehr P (2003) Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol 56:968–976CrossRefPubMedGoogle Scholar
  34. 34.
    Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41:861–870PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    Zaal IJ, Devlin JW, Peelen LM, Slooter AJC (2015) Systematic review of risk factors for delirium in the ICU. Crit Care Med 43:40–47CrossRefPubMedGoogle Scholar
  36. 36.
    Devlin JW, Roberts RJ (2011) Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Anesthesiol Clin 29:567–585CrossRefPubMedGoogle Scholar
  37. 37.
    Skrobik Y, Leger C, Cossette M, Michaud V, Turgeon J (2013) Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 41:999–1008CrossRefPubMedGoogle Scholar
  38. 38.
    Klein Klouwenberg PM, Zaal IJ, Spitoni C et al (2014) The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ 24:349Google Scholar
  39. 39.
    Jakob SM, Ruokonen E, Grounds RM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307:1151–1160CrossRefPubMedGoogle Scholar
  40. 40.
    Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA (2009) Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 50:206–217CrossRefPubMedGoogle Scholar
  41. 41.
    Pandharipande PP, Pun BT, Herr DL et al (2007) Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298:2644–2653CrossRefPubMedGoogle Scholar
  42. 42.
    Riker RR, Shehabi Y, Bokesch PM et al (2009) Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301:489–499CrossRefPubMedGoogle Scholar
  43. 43.
    Carson SS, Kress JP, Rodgers JE et al (2006) A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 34(5):1326–1332CrossRefPubMedGoogle Scholar
  44. 44.
    Schweickert WD, Pohlman MC, Pohlman AS et al (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373:1874–1882CrossRefPubMedGoogle Scholar
  45. 45.
    Shehabi Y, Chan L, Kadiman S et al (2013) Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med 39:910–918PubMedCentralCrossRefPubMedGoogle Scholar
  46. 46.
    van den Boogaard M, Schoonhoven L, van der Hoeven JG et al (2012) Incidence and short-term consequences of delirium in critically ill patients: a prospective observational cohort study. Int J Nurs Stud 49:775–783CrossRefPubMedGoogle Scholar
  47. 47.
    Patel SB, Poston JT, Pohlman A, Hall JB, Kress JP (2014) Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med 189:658–665CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2015

Authors and Affiliations

  • Irene J. Zaal
    • 1
  • John W. Devlin
    • 2
    • 3
  • Marijn Hazelbag
    • 4
  • Peter M. C. Klein Klouwenberg
    • 1
    • 4
    • 5
  • Arendina W. van der Kooi
    • 1
  • David S. Y. Ong
    • 1
    • 4
    • 5
  • Olaf L. Cremer
    • 1
  • Rolf H. Groenwold
    • 4
  • Arjen J. C. Slooter
    • 1
  1. 1.Department of Intensive Care MedicineUniversity Medical Center UtrechtUtrechtThe Netherlands
  2. 2.School of PharmacyNortheastern UniversityBostonUSA
  3. 3.Division of Pulmonary, Critical Care, and Sleep MedicineTufts Medical CenterBostonUSA
  4. 4.Julius Center for Health Sciences and Primary CareUniversity Medical Center UtrechtUtrechtThe Netherlands
  5. 5.Department of Medical MicrobiologyUniversity Medical Center UtrechtUtrechtThe Netherlands

Personalised recommendations